New Enterprise Associates 16, L.P.

Average Profitability
3.67%
Insider Buys Quantity
5
Insider Buys Sum
$78.27M
Insider Sells Quantity
1
Insider Sells Sum
$3,000.48

Insider Activity of New Enterprise Associates 16, L.P.

According to the SEC Form 4 filings, New Enterprise Associates 16, L.P., being in a position of

  1. 10 percent owner at Marker Therapeutics, Inc.,
    оver the last 12 months, has bought 554250 shares for $1.77M, and sold 0 shares,
    over all time since 2021-03-16, has bought 6268535 shares for $11.77M, and sold 0 shares.

The largest purchase of all time was on 2019-05-09 and amounted to 5000000 shares of Trevi Therapeutics, Inc. for $50M.

The largest sale of all time was on 2020-04-03 and amounted to 1128 shares of Trevi Therapeutics, Inc. for $3,000.

Biography of New Enterprise Associates 16, L.P.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$1,773,6001100
Sells
$000

Comparison of Insiders on Amount of Buys and Sells

2024-12-23PurchaseMarker Therapeutics, Inc.
MRKR
10 percent owner
554,250
5.7713%
$3.20$1.77M-45.61%
2021-10-18PurchaseTrevi Therapeutics, Inc.
TRVI
10 percent owner
3.7M
11.1305%
$0.81$3M+63.35%
2021-03-16PurchaseMarker Therapeutics, Inc.
MRKR
10 percent owner
5.71M
9.5207%
$1.75$10M-4.3%
2020-04-03SaleTrevi Therapeutics, Inc.
TRVI
10 percent owner
1,128
0.0062%
$2.66$3,000+19.07%
2019-07-22PurchaseMirum Pharmaceuticals, Inc.
MIRM
10 percent owner
900,000
5.3814%
$15.00$13.5M+5.09%
2019-05-09PurchaseTrevi Therapeutics, Inc.
TRVI
10 percent owner
5M
34.6117%
$10.00$50M-42.9%
Total: 6
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.